A

Arsanis

5 employees

Arsanis is a biopharmaceutical company developing infectious disease treatments based on bacterial protein and carbohydrate antigens.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Life Science

Date founded

2010

Funding rounds raised

Total raised

$46M

from 13 investors over 13 rounds

A

Arsanis raised $46M on April 26, 2017

Investors: OrbiMed Advisors, Bill & Melinda Gates Foundation, Polaris Partners, EMBL Ventures and SV Life Sciences

A

Arsanis raised $9.3M on February 27, 2017

Investors: Bill & Melinda Gates Foundation

A

Arsanis raised $15M on April 27, 2016

Investors: SV Life Sciences

A

Arsanis raised $63K on October 1, 2014

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

A

Arsanis raised $20M on September 3, 2013

Investors: SV Life Sciences and OrbiMed Advisors

A

Arsanis raised $10M on February 28, 2011

Investors: Polaris Partners, SV Life Sciences and OrbiMed Advisors

FAQ